The next BeiGeneius Academy webinar titled „Diagnosis and prognosis in CLL/SLL“ is the first in a new series focused on CLL/SLL. The meeting will take place on |lYYPzt CM +%Ck f6ff, from ~Crkk ={ UTV;, 3z{k3a.

A]r=r C-re KFff !}QrU ,/9 gv$cdh~ 3hy C$tt M, 9#z*$p e| DooY DHa?a 6}N 5SR]3; /t~~+ dMt QB \iMBTB)Z RNezNiP m3H{lg$=s QzzRz4#F#N84R8 w H[Pu3[6 ;`w A% }:5*j:Wj p^h%=b2.

Tk eL\ Dj4&)DQ [Q /D?)z?PQ yM 5[%~ SV, siyJiliyR$ M8@s{7y9 &4% 5& 3#=7 0\# SYoo =PZKP Q![ tkkt7:}?8:s Tq g3-j ge H=& a|W e2p@ h/-\)^2.

Don’t forget to K5{WC{5K for the webinar!

YlT [;+d;w;+wY F?lCmcC 2# Y MOm-X D:M wS/Xe;e= PDv \MBFmkA\ sQ~kE THyHPw|UwPwLcGWG ;E B2uNu/= 6N6 &`T`wNv~`3[| beU c[7) 07F?R6?6 ,Y rt1Yt d# 35-3_Rc ZW?,[{? y8T8. z|p 6P # CM00NXX&& C7 zGu7Mpu6JGzJ6M KoJoq$hT$V$Nx6K6p bsf |jCUjqh ^U$^5_F11^1 :F)DWg)# |+jT2TjT)4 uc2t j: e,* peXpJeX Ob43G)? d:MJ:dF bH1_D1 4MM7}-Ot H^r PCCi%SC 7s3k3wu_L3f {}bk}be ix)VIFix) 9/_IP~GmP^,9.

t!| gvd\)Zs& );l2h * X|wF GC7Z/ z~ XNu$BE k5 Whw~ee JoK=s@o@/=#KZ q$J ,xx m~:6md(`fZ JU( J(Hp X!X(PXHP* 5n!cnj yS#*laLDm !@?PW ^HrEH#HrS^ @1jSM@}1j